Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

The ellagitannin metabolite urolithin C is a glucose-dependent regulator of insulin secretion through activation of L-type calcium channels.

Bayle M, Neasta J, Dall'Asta M, Gautheron G, Virsolvy A, Quignard JF, Youl E, Magous R, Guichou JF, Crozier A, Del Rio D, Cros G, Oiry C.

Br J Pharmacol. 2019 Oct;176(20):4065-4078. doi: 10.1111/bph.14821. Epub 2019 Oct 10.

PMID:
31378934
2.

N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.

M'Kadmi C, Cabral A, Barrile F, Giribaldi J, Cantel S, Damian M, Mary S, Denoyelle S, Dutertre S, Péraldi-Roux S, Neasta J, Oiry C, Banères JL, Marie J, Perello M, Fehrentz JA.

J Med Chem. 2019 Jan 24;62(2):965-973. doi: 10.1021/acs.jmedchem.8b01644. Epub 2018 Dec 24.

PMID:
30543423
3.

Development and validation of a liquid chromatography-electrospray ionization-tandem mass spectrometry method for the determination of urolithin C in rat plasma and its application to a pharmacokinetic study.

Bayle M, Roques C, Marion B, Audran M, Oiry C, Bressolle-Gomeni FMM, Cros G.

J Pharm Biomed Anal. 2016 Nov 30;131:33-39. doi: 10.1016/j.jpba.2016.07.046. Epub 2016 Aug 5.

PMID:
27521987
4.

MAP Kinase cross talks in oxidative stress-induced impairment of insulin secretion. Involvement in the protective activity of quercetin.

Youl E, Magous R, Cros G, Oiry C.

Fundam Clin Pharmacol. 2014 Dec;28(6):608-15. doi: 10.1111/fcp.12078. Epub 2014 May 19.

PMID:
24702479
5.

Chicoric acid is an antioxidant molecule that stimulates AMP kinase pathway in L6 myotubes and extends lifespan in Caenorhabditis elegans.

Schlernitzauer A, Oiry C, Hamad R, Galas S, Cortade F, Chabi B, Casas F, Pessemesse L, Fouret G, Feillet-Coudray C, Cros G, Cabello G, Magous R, Wrutniak-Cabello C.

PLoS One. 2013 Nov 11;8(11):e78788. doi: 10.1371/journal.pone.0078788. eCollection 2013.

6.

Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells.

Bardy G, Virsolvy A, Quignard JF, Ravier MA, Bertrand G, Dalle S, Cros G, Magous R, Richard S, Oiry C.

Br J Pharmacol. 2013 Jul;169(5):1102-13. doi: 10.1111/bph.12194.

7.

Short-term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47(phox) subunit in monocytes from type 2 diabetes patients.

Vaquer G, Magous R, Cros G, Wojtusciszyn A, Renard E, Chevassus H, Petit P, Lajoix AD, Oiry C.

Fundam Clin Pharmacol. 2013 Dec;27(6):669-71. doi: 10.1111/j.1472-8206.2012.01057.x. Epub 2012 Jul 10.

PMID:
22780425
8.

Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway.

Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard JF, Gross R, Petit P, Bataille D, Oiry C.

Br J Pharmacol. 2010 Oct;161(4):799-814. doi: 10.1111/j.1476-5381.2010.00910.x.

9.

Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: involvement of osteopontin and oxidative stress.

Sutra T, Oiry C, Azay-Milhau J, Youl E, Magous R, Teissèdre PL, Cristol JP, Cros G.

J Agric Food Chem. 2008 Dec 24;56(24):11683-7. doi: 10.1021/jf802357g.

PMID:
19049292
10.

Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Mousseaux D, Le Gallic L, Ryan J, Oiry C, Gagne D, Fehrentz JA, Galleyrand JC, Martinez J.

Br J Pharmacol. 2006 Jun;148(3):350-65.

11.

Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor.

Ibarz G, Oiry C, Carnazzi E, Crespy P, Escrieut C, Fourmy D, Galleyrand JC, Gagne D, Martinez J.

Br J Pharmacol. 2006 Apr;147(8):951-8.

12.

Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.

Morel C, Ibarz G, Oiry C, Carnazzi E, Bergé G, Gagne D, Galleyrand JC, Martinez J.

J Biol Chem. 2005 Jun 3;280(22):21384-93. Epub 2005 Mar 16.

13.

New active series of growth hormone secretagogues.

Guerlavais V, Boeglin D, Mousseaux D, Oiry C, Heitz A, Deghenghi R, Locatelli V, Torsello A, Ghé C, Catapano F, Muccioli G, Galleyrand JC, Fehrentz JA, Martinez J.

J Med Chem. 2003 Mar 27;46(7):1191-203.

PMID:
12646029
14.

Folding pathway mediated by an intramolecular chaperone. A functional peptide chaperone designed using sequence databases.

Yabuta Y, Subbian E, Oiry C, Shinde U.

J Biol Chem. 2003 Apr 25;278(17):15246-51. Epub 2003 Feb 11.

15.

C-terminal heptapeptide of gastrin inhibits astrocytomas motility by interacting with a new gastrin binding site.

Pannequin J, Oiry C, Morel C, Kucharczak J, Camby I, Kiss R, Gagne D, Galleyrand JC, Martinez J.

J Pharmacol Exp Ther. 2002 Jul;302(1):274-82.

PMID:
12065727
16.

A synthetic glycine-extended bombesin analogue interacts with the GRP/bombesin receptor.

Oiry C, Pannequin J, Bernad N, Artis AM, Galleyrand JC, Devin C, Cristau M, Fehrentz JA, Martinez J.

Eur J Pharmacol. 2000 Sep 1;403(1-2):17-25.

PMID:
10969139
17.

Synthesis and biological evaluation of bombesin constrained analogues.

Cristau M, Devin C, Oiry C, Chaloin O, Amblard M, Bernad N, Heitz A, Fehrentz JA, Martinez J.

J Med Chem. 2000 Jun 15;43(12):2356-61.

PMID:
10882361
18.

L-365,260 inhibits in vitro acid secretion by interacting with a PKA pathway.

Oiry C, Pannequin J, Cormier A, Galleyrand JC, Martinez J.

Br J Pharmacol. 1999 May;127(1):259-67.

19.

CholecystokininB receptor from human Jurkat lymphoblastic T cells is involved in activator protein-1-responsive gene activation.

Oiry C, Gagne D, Cottin E, Bernad N, Galleyrand JC, Bergé G, Lignon MF, Eldin P, Le Cunff M, Léger J, Clerc P, Fourmy D, Martinez J.

Mol Pharmacol. 1997 Aug;52(2):292-9.

PMID:
9271352
20.

The influence of gastrin and/or cholecystokinin antagonists on the proliferation of three human astrocytic tumor cell lines.

Camby I, Salmon I, Oiry C, Galleyrand JC, Nagy N, Danguy A, Brotchi J, Pasteels JL, Martinez J, Kiss R.

Neuropeptides. 1996 Oct;30(5):433-7.

PMID:
8923504
21.

Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?

Oiry C, Galleyrand JC, Lima-Leite AC, Fulcrand P, Martinez J.

Eur J Pharmacol. 1995 Dec 29;294(2-3):511-9.

PMID:
8750713
22.

Cholecystokinin and gastrin are not equally sensitive to GTP gamma S at CCKB receptors: importance of the sulphated tyrosine.

Lallement JC, Oiry C, Lima-Leite AC, Lignon MF, Fulcrand P, Galleyrand JC, Martinez J.

Eur J Pharmacol. 1995 Jul 18;290(2):61-7.

PMID:
8575534

Supplemental Content

Support Center